Pulin Patel, DO
Allergy & Immunology · Mount Clemens, MINPI 1710950951
Payments from drug & device makers
Across 1,566 payments — averaging $274.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$128K
- AstraZeneca$105K
- Regeneron Healthcare Solutions, Inc.$89K
- ARS Pharmaceuticals Operations, Inc.$31K
- Takeda Pharmaceuticals U.S.A., Inc.$22K
- Boehringer Ingelheim$13K
- plus $41K from 40 others
What the payments were for
- Consulting fees$27,4526%
- Speaking & faculty fees$341,52479%
- Travel & lodging$20,6605%
- Food & beverage$40,4639%
- Education$5390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$430,638 in reported general payments places this provider in the 90th percentile of 119 allergy & immunology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 148 | $594,834 |
| XolairOmalizumab | 145 | $478,440 |
| HyqviaIgg/Hyaluronidase,recombinant | 35 | $296,833 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 30 | $261,048 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 76 | $248,733 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 203 | $162,298 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 18 | $134,213 |
| FasenraBenralizumab | 19 | $115,201 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $88,927 |
| NucalaMepolizumab | 22 | $78,136 |
| Spiriva RespimatTiotropium Bromide | 91 | $60,815 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 49 | $37,367 |
| Breo ElliptaFluticasone/Vilanterol | 72 | $32,635 |
| Advair HfaFluticasone Propion/Salmeterol | 61 | $23,344 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 66 | $22,386 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Genentech, Inc.Xolair | $289 | $478,440145 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Hyqvia, Gammagard Liquid | $22,410 | $431,04553 claims |
| CSL BehringHizentra, Privigen | $1,600 | $349,97543 claims |
| GSKTrelegy Ellipta, Nucala, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $2,427 | $290,539324 claims |
| Grifols USA, LLCGamunex-C | $453 | $248,73376 claims |
| AstraZenecaFasenra, Breztri Aerosphere, Symbicort, Bevespi Aerosphere | $105,234 | $173,322131 claims |
| Boehringer IngelheimSpiriva Respimat, Stiolto Respimat | $13,299 | $70,411104 claims |
| Hikma Pharmaceuticals USAEpinephrine | $14 | $15,61760 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 119 allergy & immunology providers in Michigan.
Other allergy & immunology in Mount Clemens
- Jeffrey LefleinYpsilanti$7.9M
- Cem AkinNorthville$3M
- Alan BaptistAnn Arbor$2.5M
- Suresh AnneFlint$1.1M
- Steven StrykCanton$949K
- Hassan NasirWest Branch$736K
- Theodore KelbelGrand Rapids$695K
- Rajan RavikumarBrighton$661K
- Georgiana SandersAnn Arbor$607K
- Nicholas HartogGrand Rapids$581K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.